Cancer diagnostic test based on NGS and IHC technology
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
936
NCT05058937
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
Phase: N/A
Role: Collaborator
Start: Jun 1, 2021
Completion: May 31, 2026
Loading map...